Brian Hotchkiss

Brian Hotchkiss

Company: Stealth Biotherapeutics

Job title: Executive Vice President of Ophthalmology


ReCLAIM-2: Phase 2 Trial of Subcutaneous Elamipretide in Patients with Noncentral Geographic Atrophy 12:30 pm

Elamipretide is a first in class mitochondrial restorative compound Review results of phase 2 trial demonstrating positive secondary endpoints and possible path to phase 3 enrichment Cover ellipsoid zone endpoint and how it relates to mitochondrial healthRead more

day: Day Two

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.